IBMDx study
Gene: FANCM
Various studies [PMID: 28837162, 28837157, 34793962, 31942822] have demonstrated that biallelic FANCM mutations should be considered within the spectrum of FA-like syndromes, mainly characterized by increased risk for breast and other types of cancer, and chemotherapy toxicity without preceding overt marrow failure or congenital abnormalities. In vitro cellular studies and FANCM deficient mice models [PMID: 19423727, 19561169, 25010009] support the hypersensitivity to chemotherapy agents and cancer predisposition being associated with FANCM mutations.Created: 9 Feb 2022, 11:43 p.m. | Last Modified: 9 Feb 2022, 11:43 p.m.
Panel Version: 0.2
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
FA-like syndromes, mainly characterized by increased risk for breast and other types of cancer, and chemotherapy toxicity
Publications
The association between FANCM and FA is considered REFUTED.Created: 23 Jul 2020, 11:45 p.m. | Last Modified: 23 Jul 2020, 11:45 p.m.
Panel Version: 0.67
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Fanconi anaemia
Publications
Gene: fancm has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: FANCM were changed from Fanconi anaemia to FA-like syndromes, chemotherapy toxicity
Publications for gene: FANCM were set to
Mode of inheritance for gene: FANCM was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
Gene: fancm has been classified as Amber List (Moderate Evidence).
gene: FANCM was added gene: FANCM was added to IBMDx study. Sources: IBMDx Study,Expert Review Green Mode of inheritance for gene: FANCM was set to Unknown Phenotypes for gene: FANCM were set to Fanconi anaemia